BioSpace News Archive

Senti Bio, a leading gene circuit company, today announced that its co-founder and chief executive officer, Tim Lu, MD, PhD, has been appointed to the Alliance for Regenerative Medicine’s (ARM) 2022 Board of Directors.

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today priced its previously announced underwritten public offering of 50 million shares of its common stock at a public offering price of $1.00 per share.

Medtronic plc (NYSE:MDT), today announced Austin L. Chiang, M.D., M.P.H., assistant professor of medicine at Sidney Kimmel Medical College, chief medical social media officer of Jefferson Health and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, has joined Medtronic as Chief Medical Officer (CMO).

Speclipse, a startup specializing in laser spectroscopic and AI-based medical diagnostic technologies and a member of Born2Global Centre, was recently included in MedTech Outlook’s “Top 10 Non Invasive Device Companies” ranking for 2021.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it will release its third quarter 2021 financial results before the market opens on Thursday, November 4, 2021.

Alphatec Holdings, Inc., a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced that it will report third quarter 2021 financial results on November 4, 2021, after the market close.

PharmaJet®, the maker of innovative, needle-free injection technology, announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia delivering inactivated polio vaccine to more than 110,000 children.

Longbow Immunotherapy, a newly formed biotech advancing solid tumor therapy, announced its formation and exclusive license of the ReACT platform from the Versiti Blood Research Institute.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced the signing of a collaboration agreement granting China Resources Double-Crane Pharmaceutical Co., Ltd. (CRDC) exclusive Asia territorial rights to develop a novel investigational oral COVID-19 antiviral therapeutic compound using Ligand’s BEPro technology.

uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced the appointment of Rachelle Jacques to its Board of Directors.